You’re cruising through a heme/onc Q-bank and a vignette screams “platelets,” but the answer choices try to lure you into leukemia land, reactive causes, and other myeloproliferative neoplasms. Essential thrombocythemia (ET) is one of those Step-friendly diagnoses where you can score easy points if you know (1) the core pattern and (2) how to eliminate distractors fast.
The Vignette (Classic Q-Bank Style)
A 58-year-old woman is evaluated for intermittent headaches and episodic burning pain in her fingertips that improves with aspirin. She has no fever or weight loss. Exam shows mild splenomegaly. Labs reveal:
- Platelets: 1,100,000/µL
- Hemoglobin: 12.8 g/dL
- WBC: 9,000/µL
- Peripheral smear: markedly increased platelets, some large forms
- PT/aPTT: normal
Question: Which of the following is the most likely diagnosis?
The Correct Answer: Essential Thrombocythemia (ET)
Why ET fits
ET is a myeloproliferative neoplasm (MPN) characterized by sustained thrombocytosis due to clonal megakaryocyte proliferation.
High-yield clinical clues:
- Very high platelets (often > 450k, can exceed 1 million)
- Microvascular thrombosis symptoms:
- Headache, dizziness
- Visual changes
- Erythromelalgia (burning pain/redness in hands/feet) — classically improves with aspirin
- Splenomegaly can occur (extramedullary hematopoiesis)
- Can have both thrombosis and bleeding
- Bleeding risk increases at extreme platelet counts due to acquired von Willebrand disease (platelets “soak up” vWF multimers)
Pathogenesis and genetics (Step 1/2 relevant)
Most ET cases involve mutations that activate JAK-STAT signaling:
- JAK2 (most common)
- CALR
- MPL
Key concept: ET is clonal (neoplastic), so it’s not just “reactive platelets.”
Diagnosis: what they want you to know
ET is diagnosed by:
- Persistent thrombocytosis
- Excluding reactive causes and other MPNs
- Bone marrow (if tested): increased megakaryocytes (often enlarged, hyperlobulated)
Management (board-relevant overview)
- Low-dose aspirin for microvascular symptoms and thrombosis prevention (if no major contraindication)
- Cytoreduction (e.g., hydroxyurea) for higher-risk patients (older age, prior thrombosis, very high platelets)
- If bleeding with very high platelets → think acquired vWD → aspirin may worsen bleeding
Why Every Answer Choice Matters (Systematic Distractor Breakdown)
Below are the “usual suspects” that show up alongside ET. The trick is recognizing what doesn’t fit the vignette.
1) Reactive (Secondary) Thrombocytosis
Why it’s tempting: Platelets are high, and reactive thrombocytosis is common.
Why it’s wrong here: Reactive thrombocytosis is driven by inflammation or stress, so you’d expect a cause like:
- Infection/inflammation (↑ IL-6)
- Iron deficiency
- Hemorrhage/hemolysis
- Malignancy
- Post-splenectomy state
How Step clues point away:
- ET tends to have MPN-type symptoms (erythromelalgia, thrombosis, splenomegaly)
- Reactive thrombocytosis usually does not cause dramatic microvascular ischemic symptoms like classic aspirin-responsive erythromelalgia
High-yield pearl: Reactive thrombocytosis rarely causes major thrombosis compared with clonal thrombocytosis.
2) Polycythemia Vera (PV)
Why it’s tempting: Another JAK2-associated MPN; thrombosis and splenomegaly overlap.
Why it’s wrong here: PV is defined by increased red cell mass:
- ↑ Hemoglobin/hematocrit
- Often low EPO
- Symptoms: pruritus after hot shower, plethora, thrombosis
Fast elimination:
- This patient’s hemoglobin is normal and the vignette is platelet-dominant.
High-yield overlap: PV can also have thrombocytosis, but RBC elevation is the anchor.
3) Primary Myelofibrosis (PMF)
Why it’s tempting: MPN with splenomegaly; can have variable platelets early.
Why it’s wrong here: PMF is marrow scarring with extramedullary hematopoiesis:
- Progressive anemia
- Massive splenomegaly
- Peripheral smear: teardrop RBCs (dacrocytes), leukoerythroblastosis
- “Dry tap” on bone marrow aspiration
Fast elimination:
- The vignette doesn’t mention anemia, teardrops, or dramatic systemic symptoms.
4) Chronic Myeloid Leukemia (CML)
Why it’s tempting: Another MPN; can have thrombocytosis.
Why it’s wrong here: CML is driven by BCR-ABL (Philadelphia chromosome t(9;22)), causing:
- Marked leukocytosis with left shift (myelocytes, metamyelocytes)
- Basophilia/eosinophilia
- Splenomegaly
- Low leukocyte alkaline phosphatase (classic association)
Fast elimination:
- WBC count here is normal and the smear is platelet-heavy, not granulocyte-heavy.
5) Immune Thrombocytopenia (ITP)
Why it’s tempting: “Platelet disorder” appears in answer choices, and students sometimes anchor on platelets in general.
Why it’s wrong here: ITP is isolated thrombocytopenia, not thrombocytosis:
- Platelets are low
- Mucocutaneous bleeding (petechiae, epistaxis)
- Often follows viral infection in kids; associated with autoimmune disease in adults
Fast elimination:
- Platelets here are extremely high, so ITP is the opposite pattern.
6) Acute Leukemia (e.g., AML/ALL)
Why it’s tempting: Heme malignancy distractor; sometimes thrombocytopenia + bleeding is featured.
Why it’s wrong here: Acute leukemia typically causes marrow failure:
- Anemia + thrombocytopenia (not thrombocytosis)
- Fatigue, infection, bleeding
- Blasts on smear
Fast elimination:
- This patient has isolated thrombocytosis with microvascular symptoms—not pancytopenia or blasts.
7) Hodgkin Lymphoma / Non-Hodgkin Lymphoma
Why it’s tempting: The question stem says “Heme/Onc,” and lymphomas show up everywhere.
Why it’s wrong here: Lymphomas present with:
- Lymphadenopathy
- “B symptoms” (fever, night sweats, weight loss)
- Sometimes cytopenias (marrow involvement), not isolated extreme thrombocytosis
Fast elimination:
- No lymph nodes, no B symptoms, no marrow failure pattern.
One Table to Lock It In: ET vs Look-Alikes
| Condition | Key Lab Pattern | Signature Clues | Key Differentiator |
|---|---|---|---|
| Essential thrombocythemia | ↑↑ Platelets (often > 1M), other lines often normal | Erythromelalgia, thrombosis/bleeding, mild splenomegaly | JAK2/CALR/MPL; clonal megakaryocytes |
| Reactive thrombocytosis | ↑ Platelets | Inflammation, iron deficiency, infection, malignancy | Underlying trigger; less classic microvascular ischemia |
| Polycythemia vera | ↑ Hct/Hgb (± ↑ platelets) | Aquagenic pruritus, plethora, thrombosis | Low EPO; RBC mass drives picture |
| CML | ↑↑ WBC with left shift | Basophilia, splenomegaly | BCR-ABL (t(9;22)) |
| Primary myelofibrosis | Anemia ± variable platelets | Teardrop cells, massive splenomegaly, “dry tap” | Fibrotic marrow + leukoerythroblastosis |
| ITP | ↓ Platelets | Petechiae, mucosal bleeding | Autoimmune platelet destruction |
USMLE “Gotchas” You’re Expected to Know
ET = thrombosis and bleeding
- Thrombosis: due to increased platelets + abnormal function
- Bleeding: especially when platelets are extremely high → acquired vWD
- Mechanism: loss of high-molecular-weight vWF multimers
- Clinical: mucosal bleeding, easy bruising despite high platelets
Aspirin detail that shows up in vignettes
- Erythromelalgia improves with aspirin (microvascular platelet aggregation phenomenon).
- If there’s significant bleeding or concern for acquired vWD, aspirin can be harmful—expect nuance in higher-level questions.
Don’t let the “WBC Disorders & Lymphomas” tag throw you
ET is an MPN (myeloid stem cell disorder). Q-banks sometimes bundle it near leukemia/lymphoma questions because the testable skill is discriminating among hematologic malignancies using labs + smear + symptoms.
Quick Answer-Choice Strategy (What to Scan First)
- Which cell line is truly driving the case? Platelets vs WBC vs RBC
- Any “signature smear” clue? Teardrops (PMF), left shift (CML), blasts (acute leukemia)
- Any hallmark symptom?
- Aquagenic pruritus → PV
- Erythromelalgia → ET
- B symptoms + nodes → lymphoma
- Is there a trigger suggesting reactive? Infection, inflammation, iron deficiency, post-op, malignancy
Takeaway
In ET, the exam wants you to recognize sustained, clonal thrombocytosis with microvascular ischemic symptoms (erythromelalgia) and to rule out reactive causes and other MPNs by checking what’s happening to the other cell lines and the peripheral smear pattern.